
Long Oligo Pool Synthesis for Capture Market Report 2026
Global Outlook – By Product Type (Custom Capture Probe Libraries, Pre Designed Capture Panels, Capture Reagent Kits, Amplification And Enrichment Reagents, Design Software And Analytical Tools), By Synthesis Method (Array-Based Synthesis, Column-Based Synthesis, Microfluidic Synthesis, Other Synthesis Methods), By Application (Targeted Sequencing, Gene Synthesis, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening, Synthetic Biology, Other Applications), By End-Users (Academic And Research Institutes, Biotechnology And Pharmaceutical Companies, Clinical Laboratories, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035
Long Oligo Pool Synthesis for Capture Market Overview
• Long Oligo Pool Synthesis for Capture market size has reached to $1.73 billion in 2025 • Expected to grow to $3.31 billion in 2030 at a compound annual growth rate (CAGR) of 13.9% • Growth Driver: Rising Adoption Of Precision Medicine Driving The Growth Of The Market Due To Increasing Use Of Genomic Sequencing And Targeted Therapies • Market Trend: Strategic Collaborations Driving Innovation In High-Complexity Oligo Library Development For Advanced Genomic Applications • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Long Oligo Pool Synthesis for Capture Market?
Long oligo pool synthesis for capture is a technique that produces a large set of custom long oligonucleotides simultaneously. These oligonucleotides are designed to hybridize with specific nucleic acid sequences, enabling selective enrichment of target regions. Long oligo pool synthesis for the capture method allows high-throughput, precise, and cost-effective generation of probes for downstream applications in sequencing or molecular assays. The main product types of long oligo pool synthesis for capture include custom capture probe libraries, pre-designed capture panels, capture reagent kits, amplification and enrichment reagents, and design software and analytical tools. Custom capture probe libraries are collections of synthetic oligonucleotides designed to selectively capture genomic regions of interest for downstream sequencing or analysis. The synthesis methods include array-based synthesis, column-based synthesis, microfluidic synthesis, and other synthesis methods. They find application in targeted sequencing, Gene Synthesis, clustered regularly interspaced short palindromic repeats (CRISPR) screening, synthetic biology, and other applications, serving end users including academic and research institutes, biotechnology and pharmaceutical companies, clinical laboratories, and other end users.
What Is The Long Oligo Pool Synthesis for Capture Market Size and Share 2026?
The long oligo pool synthesis for capture market size has grown rapidly in recent years. It will grow from $1.73 billion in 2025 to $1.97 billion in 2026 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to growth in next generation sequencing adoption, rising demand for targeted sequencing solutions, expansion of cancer genomics research, increasing use of gene panel testing, advancements in array based synthesis technologies.What Is The Long Oligo Pool Synthesis for Capture Market Growth Forecast?
The long oligo pool synthesis for capture market size is expected to see rapid growth in the next few years. It will grow to $3.31 billion in 2030 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to increasing demand for precision oncology applications, rising integration of ai driven probe design tools, growing investment in synthetic biology research, expansion of clinical genomic diagnostics, increasing need for scalable and multiplexed enrichment methods. Major trends in the forecast period include increasing adoption of high-plex target enrichment panels, growing demand for custom capture probe libraries, rising integration of automated probe design platforms, expansion of crispr screening applications, increasing focus on cost-effective high-throughput oligo synthesis.Global Long Oligo Pool Synthesis for Capture Market Segmentation
1) By Product Type: Custom Capture Probe Libraries, Pre Designed Capture Panels, Capture Reagent Kits, Amplification And Enrichment Reagents, Design Software And Analytical Tools 2) By Synthesis Method: Array-Based Synthesis, Column-Based Synthesis, Microfluidic Synthesis, Other Synthesis Methods 3) By Application: Targeted Sequencing, Gene Synthesis, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening, Synthetic Biology, Other Applications 4) By End-Users: Academic And Research Institutes, Biotechnology And Pharmaceutical Companies, Clinical Laboratories, Other End Users Subsegments: 1) By Custom Capture Probe Libraries: Human Whole Exome Probe Libraries, Human Whole Genome Targeted Probe Libraries, Cancer Specific Gene Panel Probe Libraries, Inherited Disease Gene Panel Probe Libraries, Microbial And Pathogen Target Probe Libraries, Plant And Agricultural Genomics Probe Libraries, Custom Research Target Probe Libraries 2) By Pre Designed Capture Panels: Pan Cancer Gene Panels, Hereditary Disease Screening Panels, Pharmacogenomics Testing Panels, Immunology And Inflammation Panels, Neurology Related Disorder Panels, Cardiovascular Disease Panels, Metabolic Disorder Panels 3) By Capture Reagent Kits: Hybridization Buffer Reagent Kits, Washing And Elution Reagent Kits, Blocking Oligonucleotide Reagent Kits, Target Enrichment Reagent Kits, Library Preparation Reagent Kits, Quality Control Reagent Kits 4) By Amplification And Enrichment Reagents: Polymerase Based Amplification Reagents, Isothermal Amplification Reagents, Target Enrichment Bead Reagents, Adapter Ligation Reagents, Post Capture Amplification Reagents, Purification And Cleanup Reagents 5) By Design Software And Analytical Tools: Probe Design Software Platforms, Target Region Selection Tools, Sequencing Data Alignment Tools, Variant Detection Analysis Tools, Coverage And Quality Assessment Tools, Visualization And Reporting ToolsWhat Are The Drivers Of The Long Oligo Pool Synthesis for Capture Market?
The rising demand for precision medicine approaches is expected to propel the growth of long oligo pool synthesis for the capture market going forward. Precision medicine approaches are medical strategies that tailor the prevention, diagnosis, and treatment of diseases to individual patients based on their unique characteristics. The demand for precision medicine approaches is growing due to the increasing use of genomic sequencing, which enables personalized and more effective treatments. Long oligo pool synthesis for capture advances precision medicine by enabling highly specific genomic enrichment and probe design, which are essential for targeted sequencing, biomarker discovery, and patient stratification in clinical and research settings. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the U.S. Food and Drug Administration (FDA) approved 16 new personalized treatments for patients with rare diseases, a significant increase from the six approvals in 2022. Among these newly approved treatments, seven are cancer drugs, while three address other diseases and conditions. Therefore, the rising demand for precision medicine approaches is driving the growth of long oligo pool synthesis for the capture market. The increasing prevalence of genetic disorders is expected to propel the growth of long oligo pool synthesis for the capture market going forward. Genetic disorders are conditions caused by changes or mutations in an individual’s DNA that can affect health and development. The prevalence of genetic disorders is rising due to advances in medical diagnostics and genetic screening, which allow more cases to be detected and accurately diagnosed than before. Long oligo pool synthesis for capture enables the precise targeting and enrichment of specific genetic regions, allowing researchers and clinicians to efficiently identify mutations and variations responsible for genetic disorders, which supports accurate diagnosis, personalized treatment, and the development of targeted therapies. For instance, in October 2024, according to the Cystic Fibrosis Trust, a UK-based national charity, 11,148 people were living with cystic fibrosis (CF) in the UK in 2022, increasing to 11,318 in 2023. Therefore, the increasing prevalence of genetic disorders is driving the growth of long oligo pool synthesis for the capture market.Key Players In The Global Long Oligo Pool Synthesis for Capture Market
Major companies operating in the long oligo pool synthesis for capture market are Eurofins Genomics GmbH, Agilent Technologies Inc, BGI Genomics, GenScript Biotech Corporation, Twist Bioscience Corporation, Azenta Inc, DNA Script SAS, Synbio Technologies Inc, LGC Biosearch Technologies Inc, Bioneer Corporation, Gene Universal Inc, Ansa Biotechnologies Inc, Microsynth AG, Daicel Arbor Biosciences, iGeneTech Bioscience Co Ltd, Moligo Technologies AB, Creative Biogene LLC, SBS Genetech Co Ltd, MaxPrecision Labs Inc, Integrated DNA Technologies, Dynegene.Global Long Oligo Pool Synthesis for Capture Market Trends and Insights
Major companies operating in the long oligo pool synthesis for the capture market are focusing on adopting strategic partnerships to accelerate the development of high-complexity custom oligo libraries for advanced genomic applications. Strategic partnerships are structured alliances between organizations that leverage complementary strengths, expertise, and market access to strengthen competitive advantage and support long-term, sustainable growth. For instance, in January 2023, Twist Bioscience Corporation, a US-based biotechnology company, partnered with Centogene N.V., a Germany-based diagnosis and research company focused on rare diseases, to launch three next-generation sequencing (NGS) target enrichment panels to advance rare disease and hereditary cancer research and diagnostics. The panels include the Twist Alliance CNTG Exome Panel (for whole exome rare disease analysis), the CNTG Rare Disease Panel (covering >2,500 genes for disorders like treatable rare diseases and metabolic issues), and the CNTG Hereditary Oncology Panel (72 genes for cancer predisposition biomarkers). They are curated from CENTOGENE's Biodatabank of nearly 700,000 diverse patients and synthesized by Twist for precise variant detection.Regional Insights
North America was the largest region in the long oligo pool synthesis for capture market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Long Oligo Pool Synthesis for Capture Market?
The long oligo pool synthesis for the capture market consists of revenues earned by entities by providing services such as barcode and index oligo pool generation for multiplexed NGS workflows and optimization and quality control (QC) services, including NGS-based validation of oligo pool uniformity and fidelity. The market value includes the value of related goods sold by the service provider or included within the service offering. The long oligo pool synthesis for the capture market also includes sales of automated parallel oligonucleotide synthesizers, precision liquid handling and microfluidic dispensing systems, and integrated oligo pool amplification and enrichment instrumentation. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data And Analysis Are Included In The Long Oligo Pool Synthesis for Capture Market Report 2026?
The long oligo pool synthesis for capture market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the long oligo pool synthesis for capture industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Long Oligo Pool Synthesis for Capture Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.97 billion |
| Revenue Forecast In 2035 | $3.31 billion |
| Growth Rate | CAGR of 13.7% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product Type, Synthesis Method, Application, End-Users |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Eurofins Genomics GmbH, Agilent Technologies Inc, BGI Genomics, GenScript Biotech Corporation, Twist Bioscience Corporation, Azenta Inc, DNA Script SAS, Synbio Technologies Inc, LGC Biosearch Technologies Inc, Bioneer Corporation, Gene Universal Inc, Ansa Biotechnologies Inc, Microsynth AG, Daicel Arbor Biosciences, iGeneTech Bioscience Co Ltd, Moligo Technologies AB, Creative Biogene LLC, SBS Genetech Co Ltd, MaxPrecision Labs Inc, Integrated DNA Technologies, Dynegene. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
